Skip to main content

Table 4 Results of Step 3 from the ANCOVA investigating the relationship between sociodemographic factors and morbidity on patients’ health-related quality of life measured using the EQ-5D

From: Health-related quality of life impact of a triple combination of olmesartan medoxomil, amlodipine besylate and hydrochlorotiazide in subjects with hypertension

Endpoint/Factors

EQ-5D Index

EQ-5D VAS

Baseline

Difference between week 54 and baseline

p value

Baseline

Difference between week 54 and baseline

p value

Age class

  

<0.0001

   

 <=60 years

0.92 (0.12)

0.00 (0.12)

    

 >60 years

0.89 (0.14)

0.00 (0.13)

    

Gender

  

0.0005

  

0.0002

 Male

0.94 (0.11)

0.00 (0.10)

 

75.6 (14.2)

−8.50 (13.59)

 

 Female

0.89 (0.15)

0.00 (0.14)

 

71.4 (15.4)

−9.30 (15.08)

 

BMI

  

0.0426

   

 <=25 kg/m2

0.94 (0.11)

0.00 (0.12)

    

 >25 to < =30 kg/m2

0.92 (0.13)

0.00 (0.12)

    

 = > 30 kg/m2

0.91 (0.13)

0.00 (0.13)

    

Diabetes

     

0.0101

 Yes

   

69.2 (15.4)

−8.60 (15.91)

 

 No

   

74.1 (14.8)

−8.90 (14.14)

 

Cardiovascular disease

     

<0.0001

 Yes

   

70.4 (14.5)

−10.90 (13.83)

 

 No

   

74.5 (15.5)

−8.10 (14.55)

 

Country (region)

     

0.0085

 Western-central countries

   

76.0 (15.5)

−7.80 (15.50)

 

 Eastern countries

   

72.0 (14.5)

−9.40 (13.81)

 

Concomitant medication for cardiovascular disease

  

0.0065

   

 Yes

0.91 (0.13)

0.00 (0.12)

    

 No

0.92 (0.12)

0.00 (0.13)

    

Concomitant medication for mental disorder

  

0.021

  

0.0263

 Yes

0.88 (0.17)

0.00 (0.19)

 

68.7 (17.8)

−10.40 (18.05)

 

 No

0.92 (0.13)

0.00 (0.12)

 

73.6 (14.7)

−8.80 (14.22)

 

Hypertension grade at baseline

     

0.0258

 Grade 1

   

80.6 (11.8)

−1.10 (11.09)

 

 Grade 2

   

73.4 (15.0)

−8.80 (14.25)

 

 Grade 3

   

72.4 (15.2)

−10.40 (15.67)

 

Achieved hypertension control by week 54

  

0.0019

   

 Yes

0.92 (0.13)

0.00 (0.12)

    

 No

0.89 (0.15)

0.00 (0.14)

    

Baseline value of respective endpoint

  

<0.0001

  

<0.0001

SeSBP changes from baseline to week 54

  

0.0010

  

0.0160

SeDPB changes from baseline to week 54

  

0.0039

  

0.0120

  1. *The baseline values (standard deviation) and differences (standard deviation) between week 54 and baseline were calculated independently of the Step 3 model.